3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
8
Breast
7
Gastrointestinal
6
Genitourinary
5
Classical hematology
2
Sarcoma
1
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Dermatologic
1
Conditions
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Melanoma
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
13
Ifosfamide
12
Doxorubicin
12
Blood Specimen Collection
12
Radiotherapy
11
Methotrexate
10
fludarabine phosphate
9
Surgical Procedures, Operative
9
Radiosurgery
9
Cyclophosphamide
9
Surveys and Questionnaires
8
Cyclosporine
8
Proton Therapy
7
Peripheral Blood Stem Cell Transplantation
7
Busulfan
7
Mycophenolic Acid
6
Melphalan
6
Whole-Body Irradiation
5
Standard of Care
5
Filgrastim
5
Etoposide
5
Early Intervention, Educational
5
Carboplatin
5
Biopsy
5
Antilymphocyte Serum
5
Vincristine
4
Temozolomide
4
Sunitinib
4
Radiation Dose Hypofractionation
4
Mesna
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Genetic Counseling
×
Sarcoma
×
Clear all
NCT05225428
2026-05-22
VERDI
Dana-Farber Cancer Institute
Phase NA
Recruiting
1,020 enrolled